{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:24:25Z","timestamp":1759530265132},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychosom Med"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Antidepressant medication use (ADM) has been shown to predict diabetes. This article assessed the role of inflammatory markers in this relationship within the Diabetes Prevention Program (DPP).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>DPP participants randomized to metformin (MET), life-style intervention (ILS), or placebo (PLB) were assessed for depression (Beck Depression Inventory [BDI]) annually, ADM use semiannually, serum inflammatory markers (C-reactive protein [CRP], interleukin 6 [IL-6]) at baseline and year 1, and diagnosis of type 2 diabetes mellitus (T2DM) semiannually (for 3.2 years).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>At baseline (<jats:italic toggle=\"yes\">N<\/jats:italic> = 3187), M (SD) body mass index was 34 (6) kg\/m<jats:sup>2<\/jats:sup> and the median (interquartile range) BDI score was 3 (1\u20137). One hundred eighty-one (5.7%) reported ADM use and 328 (10%) had BDI scores of 11 or higher. CRP and IL-6 levels did not differ by treatment group. Baseline ADM, but not BDI score, was associated with higher levels of baseline CRP adjusted for demographic, anthropometric variables, and other medications (20% higher, <jats:italic toggle=\"yes\">p<\/jats:italic> = .01). Year 1 CRP decreased for non-ADM users in the MET (\u221213.2%) and ILS (\u221234%) groups and ADM users in the ILS group (\u221229%). No associations were found with IL-6. CRP and continuous use of ADM predicted incident T2DM in the PLB group. In the ILS group, continuous and intermittent ADM, but not CRP, predicted T2DM. In the MET group, CRP predicted incident T2DM. CRP did not mediate the risk of T2DM with ADM use in any group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>ADM was significantly associated with elevated CRP and incident T2DM. In the PLB group, ADM and CRP independently predicted onset of T2DM; however, CRP did not significantly mediate the effect of ADM.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/psy.0000000000000535","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T20:20:39Z","timestamp":1507666839000},"page":"167-173","source":"Crossref","is-referenced-by-count":7,"title":["Depressive Symptoms, Antidepressant Medication Use, and Inflammatory Markers in the Diabetes Prevention Program"],"prefix":"10.1097","volume":"80","author":[{"given":"Mary","family":"de Groot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Marrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Mele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieren J.","family":"Mather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Knowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230824","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","article-title":"The prevalence of comorbid depression in adults with diabetes: a meta-analysis","volume":"24","year":"2001","journal-title":"Diabetes Care"},{"key":"bib2-20230824","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2337\/diacare.23.7.934","article-title":"Depression and poor glycemic control: a meta-analytic review of the literature","volume":"23","year":"2000","journal-title":"Diabetes Care"},{"key":"bib3-20230824","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00006842-200107000-00015","article-title":"Association of depression and diabetes complications: a meta-analysis","volume":"63","year":"2001","journal-title":"Psychosom Med"},{"key":"bib4-20230824","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/01.PSY.0000041624.96580.1F","article-title":"Depression and coronary heart disease in women with diabetes","volume":"65","year":"2003","journal-title":"Psychosom Med"},{"key":"bib5-20230824","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.genhosppsych.2009.06.007","article-title":"The effect of depression on self-care behaviors and quality of care in a national sample of adults with diabetes","volume":"31","year":"2009","journal-title":"Gen Hosp Psychiatry"},{"key":"bib6-20230824","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/gps.2363","article-title":"The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes","volume":"25","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"key":"bib7-20230824","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1001\/archinte.160.21.3278","article-title":"Depression and diabetes: Impact of depressive symptoms on adherence, function, and costs","volume":"160","year":"2000","journal-title":"Arch Intern Med"},{"key":"bib8-20230824","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/diacare.25.3.464","article-title":"Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes","volume":"25","year":"2002","journal-title":"Diabetes Care"},{"key":"bib9-20230824","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2337\/diacare.27.2.421","article-title":"Diabetes, major depression and functional disability among U.S. adults","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"bib10-20230824","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1017\/S0033291704003071","article-title":"Clinical and functional outcomes of depression treatment in patients with and without chronic medical illness","volume":"35","year":"2005","journal-title":"Psychol Med"},{"key":"bib11-20230824","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.2337\/diacare.28.11.2668","article-title":"The association of comorbid depression with mortality in patients with type 2 diabetes","volume":"28","year":"2005","journal-title":"Diabetes Care"},{"key":"bib12-20230824","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/aje\/kwi089","article-title":"Depressive symptoms and mortality among persons with and without diabetes","volume":"161","year":"2005","journal-title":"Am J Epidemiol"},{"key":"bib13-20230824","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0022-3999(02)00302-1","article-title":"Epidemiologic evidence on the comorbidity of depression and diabetes","volume":"53","year":"2002","journal-title":"J Psychosom Res"},{"key":"bib14-20230824","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2337\/diacare.22.7.1071","article-title":"Depressive symptoms and occurrence of type 2 diabetes among Japanese men","volume":"22","year":"1999","journal-title":"Diabetes Care"},{"key":"bib15-20230824","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1001\/jama.299.23.2751","article-title":"Examining a bidirectional association between depressive symptoms and diabetes","volume":"299","year":"2008","journal-title":"JAMA"},{"key":"bib16-20230824","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2337\/dc08-0985","article-title":"Depression and type 2 diabetes over the lifespan: a meta-analysis","volume":"31","year":"2008","journal-title":"Diabetes Care"},{"key":"bib17-20230824","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00125-006-0159-x","article-title":"Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis","volume":"49","year":"2006","journal-title":"Diabetologia"},{"key":"bib18-20230824","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.2337\/dc11-1223","article-title":"Elevated depressive symptoms, antidepressant use, and diabetes in a large multiethnic national sample of postmenopausal women","volume":"34","year":"2011","journal-title":"Diabetes Care"},{"key":"bib19-20230824","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2337\/dc07-1827","article-title":"Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the Diabetes Prevention Program","volume":"31","year":"2008","journal-title":"Diabetes Care"},{"key":"bib20-20230824","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2337\/dc10-1033","article-title":"Diabetes Prevention Program Research Group. Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"bib21-20230824","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.2337\/diacare.28.10.2472","article-title":"Diabetes Prevention Program Research Group. Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program","volume":"28","year":"2005","journal-title":"Diabetes Care"},{"key":"bib22-20230824","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.2337\/diabetes.54.5.1566","article-title":"Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance","volume":"54","year":"2005","journal-title":"Diabetes"},{"key":"bib23-20230824","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.phrs.2006.03.003","article-title":"Cellular inflammatory responses: novel insights for obesity and insulin resistance","volume":"53","year":"2006","journal-title":"Pharmacol Res"},{"key":"bib24-20230824","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s001250051058","article-title":"Is type II diabetes mellitus a disease of the innate immune system?","volume":"41","year":"1998","journal-title":"Diabetologia"},{"key":"bib25-20230824","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/01.ATV.0000065636.15310.9C","article-title":"C-reactive protein in independently associated with fasting insulin in non-diabetic women","volume":"23","year":"2003","journal-title":"Arteriorscler Thromb Vasc Biol"},{"key":"bib26-20230824","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","year":"2009","journal-title":"Biol Psychiatry"},{"key":"bib27-20230824","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/187152808784165216","article-title":"Inflammatory aspects of depression","volume":"7","year":"2008","journal-title":"Inflamm Allergy Drug Targets"},{"key":"bib28-20230824","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1 and IL-6: a meta-analysis","volume":"71","year":"2009","journal-title":"Psychosom Med"},{"key":"bib29-20230824","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/PSY.0b013e3180f61c5c","article-title":"Depression and type 2 diabetes mellitus: the multiethnic study of atherosclerosis","volume":"69","year":"2007","journal-title":"Psychosom Med"},{"key":"bib30-20230824","article-title":"Diabetes, depression and inflammation in older adults: results from the Health, Aging and Body Composition Study (Health ABC Study). [Abstract]","volume":"59","journal-title":"Diabetes"},{"key":"bib31-20230824","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2337\/diacare.22.4.623","article-title":"The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes","volume":"22","year":"1999","journal-title":"Diabetes Care"},{"key":"bib33-20230824","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostatis model assessment: insulin resistance and beta-cell function from fasting glucose and insulin concentrations in man","volume":"28","year":"1985","journal-title":"Diabetologia"},{"key":"bib34-20230824","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","article-title":"The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations","volume":"51","year":"1986","journal-title":"J Pers Soc Psychol"},{"key":"bib35-20230824","first-page":"583","article-title":"Depression, stress and immunological activation: the role of cytokines in depressive disorders","volume":"62","year":"1998"},{"key":"bib36-20230824","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/15622970802573246","article-title":"Pro-inflammatory biomakers in depression: treatment with venlafaxine","volume":"10","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"bib37-20230824","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1177\/0269881108091077","article-title":"Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorder","volume":"23","year":"2009","journal-title":"J Psychopharmacol"},{"key":"bib38-20230824","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00213-015-4044-5","article-title":"Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?","volume":"233","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"bib39-20230824","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1017\/S1461145702003164","article-title":"Effects of antidepressants on the production of cytokines","volume":"5","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"bib40-20230824","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2337\/dc12-0293","article-title":"Depression as a predictor of weight regain among successful weight losers in the diabetes prevention program","volume":"36","year":"2013","journal-title":"Diabetes Care"}],"container-title":["Psychosomatic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006842-201802000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T17:16:24Z","timestamp":1692897384000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006842-201802000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/psy.0000000000000535","relation":{},"ISSN":["1534-7796","0033-3174"],"issn-type":[{"value":"1534-7796","type":"electronic"},{"value":"0033-3174","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}